
Moazzam Shahzad/researchgate.net
Aug 28, 2025, 18:46
Moazzam Shahzad Shares New Insights on AlloHCT in Elderly Myelofibrosis Patients
Moazzam Shahzad, Hematologist-Oncologist at H. Lee Moffitt Cancer Center and Research Institute, shared a post on X about a paper published on Clinical Lymphoma, Myeloma and Leukemia:
“Our latest publication in CLML explores alloHCT outcomes in elderly myelofibrosis patients.”
Title: Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 65 Years and Above with Myelofibrosis
Authors: Moazzam Shahzad, Muhammad Kashif Amin, Sohaib Irfan, Rania Ahsan, Hana Qasim, Muhammad Jawad Javed, Matthew McGuirk, Sibgha Gull Chaudhary, Iqra Anwar, Abdulraheem Yacoub, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq
Read the full article.
More posts featuring Moazzam Shahzad on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 28, 2025, 18:37
Aug 28, 2025, 18:29
Aug 28, 2025, 18:28
Aug 28, 2025, 18:24
Aug 28, 2025, 18:20
Aug 28, 2025, 18:05
Aug 28, 2025, 17:59